This company has been marked as potentially delisted and may not be actively trading. Anzu Special Acquisition Corp I (ANZU) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock ANZU vs. APT, MLSS, LGMK, SRTS, VIRI, ORMP, HYPR, ADAP, NVNO, and VERUShould you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Alpha Pro Tech (APT), Milestone Scientific (MLSS), LogicMark (LGMK), Sensus Healthcare (SRTS), Virios Therapeutics (VIRI), Oramed Pharmaceuticals (ORMP), Hyperfine (HYPR), Adaptimmune Therapeutics (ADAP), enVVeno Medical (NVNO), and Veru (VERU). Anzu Special Acquisition Corp I vs. Its Competitors Alpha Pro Tech Milestone Scientific LogicMark Sensus Healthcare Virios Therapeutics Oramed Pharmaceuticals Hyperfine Adaptimmune Therapeutics enVVeno Medical Veru Anzu Special Acquisition Corp I (NASDAQ:ANZU) and Alpha Pro Tech (NYSE:APT) are both small-cap surgical appliances & supplies industry companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Is ANZU or APT more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Anzu Special Acquisition Corp I's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Anzu Special Acquisition Corp I's return on equity.Company Net Margins Return on Equity Return on Assets Anzu Special Acquisition Corp IN/A -17.33% 1.37% Alpha Pro Tech 6.99%6.70%5.76% Which has more risk and volatility, ANZU or APT? Anzu Special Acquisition Corp I has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500. Does the media refer more to ANZU or APT? In the previous week, Anzu Special Acquisition Corp I's average media sentiment score of 0.44 beat Alpha Pro Tech's score of 0.00 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the media. Company Overall Sentiment Anzu Special Acquisition Corp I Neutral Alpha Pro Tech Neutral Do institutionals and insiders have more ownership in ANZU or APT? 27.3% of Anzu Special Acquisition Corp I shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 0.7% of Anzu Special Acquisition Corp I shares are held by insiders. Comparatively, 15.0% of Alpha Pro Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, ANZU or APT? Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Alpha Pro Tech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnzu Special Acquisition Corp IN/AN/A$19.23MN/AN/AAlpha Pro Tech$58.18M0.90$4.19M$0.3713.05 SummaryAlpha Pro Tech beats Anzu Special Acquisition Corp I on 6 of the 9 factors compared between the two stocks. Get Anzu Special Acquisition Corp I News Delivered to You Automatically Sign up to receive the latest news and ratings for ANZU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANZU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANZU vs. The Competition Export to ExcelMetricAnzu Special Acquisition Corp ISurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.59M$25.01M$5.48B$9.51BDividend YieldN/AN/A4.73%4.08%P/E RatioN/A13.0528.6723.80Price / SalesN/A1.71373.9066.65Price / Cash3.7412.8035.4557.96Price / Book-0.861.618.275.55Net Income$19.23M-$5.31M$3.24B$259.03M Anzu Special Acquisition Corp I Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANZUAnzu Special Acquisition Corp IN/A$1.45-1.0%N/A-31.8%$21.59MN/A0.003Gap DownAPTAlpha Pro Tech1.3054 of 5 stars$4.77-0.2%N/A-17.1%$51.82M$58.18M12.89120News CoverageMLSSMilestone Scientific2.0397 of 5 stars$0.60flat$1.25+110.1%-55.5%$46.69M$8.61M-8.5030News CoverageLGMKLogicMark0.6589 of 5 stars$0.00-2.9%N/A-100.0%$1.96M$9.88M0.0020Gap DownSRTSSensus Healthcare1.3781 of 5 stars$5.51-2.5%$11.67+111.7%-10.7%$92.91M$41.81M55.1040News CoverageUpcoming EarningsGap DownVIRIVirios TherapeuticsN/A$4.77+0.8%$5.00+4.8%+2,247.1%$91.86MN/A-17.675Upcoming EarningsORMPOramed Pharmaceuticals0.7783 of 5 stars$2.16-3.6%N/A-10.5%$91.49M$1.34M-4.9110News CoverageAnalyst RevisionHYPRHyperfine1.0134 of 5 stars$1.08-6.1%$1.06-1.9%-11.2%$89.51M$12.89M-2.00190ADAPAdaptimmune Therapeutics2.4826 of 5 stars$0.35+4.4%$1.35+289.6%-93.7%$88.08M$178.03M-1.28490News CoverageAnalyst DowngradeAnalyst RevisionGap UpNVNOenVVeno Medical0.3597 of 5 stars$4.96-1.2%N/A-8.6%$88.03MN/A-4.2030News CoverageEarnings ReportVERUVeru1.835 of 5 stars$0.56-6.5%$4.00+613.3%-44.5%$87.95M$16.89M-2.34230News CoverageUpcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies APT Competitors MLSS Competitors LGMK Competitors SRTS Competitors VIRI Competitors ORMP Competitors HYPR Competitors ADAP Competitors NVNO Competitors VERU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANZU) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anzu Special Acquisition Corp I Please log in to your account or sign up in order to add this asset to your watchlist. Share Anzu Special Acquisition Corp I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
